Antileishmanial drug discovery: comprehensive review of the last 10 years

No abstract is available for this paper.

• Publication year

  2015

• Venue

  RSC Advances

• Publication date

  2015-04-07

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1039/C5RA02669E
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological evaluation of chalcones as potential antileishmanial agents.

  2014cited by this paper
• New antileishmanial sesquiterpene coumarins from Ferula narthex Boiss

  2014cited by this paper
• Pentacyclic triterpenoids from Mitracarpus frigidus (Willd. ex Roem. & Schult.) K. Shum: in vitro cytotoxic and leishmanicidal and in vivo anti-inflammatory and antioxidative activities

  2014cited by this paper
• Synthesis, structure-activity relationships, and biological studies of chromenochalcones as potential antileishmanial agents.

  2014cited by this paper
• Antileishmanial Activity of a Series of N2,N4-Disubstituted Quinazoline-2,4-diamines

  2014cited by this paper
• Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs.

  2014cited by this paper
• Recent Developments in Drug Discovery for Leishmaniasis and Human African Trypanosomiasis

  2014cited by this paper
• Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.

  2014cited by this paper
• Fruitful decade for antileishmanial compounds from 2002 to late 2011.

  2014cited by this paper
• Bioactive indole alkaloids isolated from Alstonia angustifolia.

  2014cited by this paper
• Synthesis, antileishmanial activity and docking study of N'-substitutedbenzylidene-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetohydrazides.

  2014cited by this paper
• Natural product based leads to fight against leishmaniasis.

  2014cited by this paper
• Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents.

  2013cited by this paper
• Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.

  2013cited by this paper
• Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.

  2013cited by this paper
• Chemotherapy of leishmaniasis. Part XII: design, synthesis and bioevaluation of novel triazole integrated phenyl heteroterpenoids as antileishmanial agents.

  2013cited by this paper
• Identification of Leishmania Species Using PCR Assay on Giemsa-Stained Slides Prepared From Cutaneous Leishmaniasis Patients

  2013cited by this paper
• Antileishmanial polyphenols from Corymbia maculata

  2013cited by this paper
• Synthesis of 2-methoxybenzoylhydrazone and evaluation of their antileishmanial activity.

  2013cited by this paper
• Discovery of triazine mimetics as potent antileishmanial agents.

  2013cited by this paper
• Discovery of 3,3'-diindolylmethanes as potent antileishmanial agents.

  2013cited by this paper
• First detection of Leishmania infantum DNA in wild caught Phlebotomus papatasi in endemic focus of cutaneous leishmaniasis, South of Iran.

  2013cited by this paper
• 5′‐Trityl‐Substituted Thymidine Derivatives as a Novel Class of Antileishmanial Agents: Leishmania infantum EndoG as a Potential Target

  2013cited by this paper
• Amphiphilic Antimony(V) Complexes for Oral Treatment of Visceral Leishmaniasis

  2013cited by this paper
• Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues.

  2012cited by this paper
• The leishmanicidal flavonols quercetin and quercitrin target Leishmania (Leishmania) amazonensis arginase.

  2012cited by this paper
• Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?

  2012cited by this paper
• Leishmaniasis: current status of available drugs and new potential drug targets.

  2012cited by this paper
• Antileishmanial bis-arylimidamides: DB766 analogs modified in the linker region and bis-arylimidamide structure-activity relationships.

  2012cited by this paper
• Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.

  2012cited by this paper
• Discovery of a new antileishmanial hit in 8-nitroquinoline series.

  2012cited by this paper
• Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.

  2012cited by this paper
• Specific and Rapid Detection of Mycobacterium tuberculosis Complex in Clinical Samples by Polymerase Chain Reaction

  2012cited by this paper
• Innovative lead compounds and formulation strategies as newer kinetoplastid therapies.

  2012cited by this paper
• Synthesis of N-(1-methyl-1H-indol-3-yl)methyleneamines and 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones as potential antileishmanial agents.

  2012cited by this paper
• Leishmaniasis Worldwide and Global Estimates of Its Incidence

  2012cited by this paper
• Developments in Diagnosis and Antileishmanial Drugs

  2012cited by this paper
• Antileishmanial activity of cryptolepine analogues and apoptotic effects of 2,7-dibromocryptolepine against Leishmania donovani promastigotes

  2012cited by this paper
• Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives.

  2011cited by this paper
• Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.

  2011cited by this paper
• Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents.

  2011cited by this paper
• Trimethoxy-chalcone derivatives inhibit growth of Leishmania braziliensis: synthesis, biological evaluation, molecular modeling and structure-activity relationship (SAR).

  2011cited by this paper
• Design, synthesis and antileishmanial in vitro activity of new series of chalcones-like compounds: a molecular hybridization approach.

  2011cited by this paper
• Drug targeting to macrophages using paromomycin-loaded albumin microspheres for treatment of visceral leishmaniasis: an in vitro evaluation

  2011cited by this paper
• Thiopurine derivatives containing triazole and steroid: synthesis, antimalarial and antileishmanial activities.

  2011cited by this paper
• Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.

  2011cited by this paper
• Synthesis of 4-aminoquinoline analogues and their platinum(II) complexes as new antileishmanial and antitubercular agents.

  2011cited by this paper
• Pterocarpanquinones, aza-pterocarpanquinone and derivatives: synthesis, antineoplasic activity on human malignant cell lines and antileishmanial activity on Leishmania amazonensis.

  2011cited by this paper
• Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles

  2011cited by this paper
• In Vitro Activities of New 2-Substituted Quinolines against Leishmania donovani

  2011cited by this paper
• Antileishmanial activity of benzocycloalkyl azole oximino ethers: the conformationally constraint analogues of oxiconazole.

  2011cited by this paper
• Inhibitors of the Purine Salvage Pathway: A Valuable Approach for Antiprotozoal Chemotherapy?

  2010cited by this paper
• Almiramides A-C: discovery and development of a new class of leishmaniasis lead compounds.

  2010cited by this paper
• Inhibitors of Leishmania GDP-Mannose Pyrophosphorylase Identified by High-Throughput Screening of Small-Molecule Chemical Library

  2010cited by this paper
• Antitrypanosomal and antileishmanial activities of novel N-alkyl-(1-phenylsubstituted-beta-carboline)-3-carboxamides.

  2010cited by this paper
• Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata.

  2010cited by this paper
• Coumarins from Galipea panamensis and Their Activity against Leishmania panamensis.

  2010cited by this paper
• Novel antileishmanial chalconoids: synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones.

  2010cited by this paper
• Chromene‐Based Synthetic Chalcones as Potent Antileishmanial Agents: Synthesis and Biological Activity

  2010cited by this paper
• Synthesis and antiprotozoal activity of 4-arylcoumarins.

  2010cited by this paper
• Antileishmanial, Antimicrobial and Antifungal Activities of Some New Aryl Azomethines

  2010cited by this paper
• Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent

  2010cited by this paper
• Synthesis and molecular docking studies of 1-phenyl-4-glycosyl-dihydropyridines as potent antileishmanial agents.

  2010cited by this paper
• Single-dose liposomal amphotericin B for visceral leishmaniasis in India.

  2010cited by this paper
• Synthesis and evaluation of original amidoximes as antileishmanial agents.

  2010cited by this paper
• Survey of Antibodies to Trypanosoma cruzi and Leishmania spp. in Gray and Red Fox Populations From North Carolina and Virginia

  2010cited by this paper
• Dragonamide E, a modified linear lipopeptide from Lyngbya majuscula with antileishmanial activity.

  2010cited by this paper
• Synthesis and biological evaluation of indolyl glyoxylamides as a new class of antileishmanial agents.

  2010cited by this paper
• Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment.

  2009cited by this paper
• Leishmanicidal effect of LLD-3 (1), a nor-triterpene isolated from Lophanthera lactescens.

  2009cited by this paper
• Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases

  2009cited by this paper
• Amphotericin B: side effects and toxicity.

  2009cited by this paper
• Paromomycin: uptake and resistance in Leishmania donovani.

  2009cited by this paper
• A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.

  2009cited by this paper
• Fighting against Leishmaniasis: search of alkaloids as future true potential anti-Leishmanial agents.

  2009cited by this paper
• Peganine hydrochloride dihydrate an orally active antileishmanial agent.

  2009cited by this paper
• Synthesis, biological evaluation and SAR of sulfonamide 4-methoxychalcone derivatives with potential antileishmanial activity.

  2009cited by this paper
• Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents.

  2009cited by this paper
• Synthesis and biological evaluation of novel 4-(hetero) aryl-2-piperazino quinazolines as anti-leishmanial and anti-proliferative agents.

  2009cited by this paper
• Glyoxalase I Gene Deletion Mutants of Leishmania donovani Exhibit Reduced Methylglyoxal Detoxification

  2009cited by this paper
• Alkaloids: future prospective to combat leishmaniasis.

  2009cited by this paper
• Pentavalent Antimonials: New Perspectives for Old Drugs

  2009cited by this paper
• Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.

  2009cited by this paper
• Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.

  2009cited by this paper
• Miltefosine Promotes IFN-γ-Dominated Anti-Leishmanial Immune Response1

  2009cited by this paper
• Identification and Characterization of a Novel Deoxyhypusine Synthase in Leishmania donovani*

  2009cited by this paper
• Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis.

  2008cited by this paper
• Synthesis and pharmacological activity of chalcones derived from 2,4,6-trimethoxyacetophenone in RAW 264.7 cells stimulated by LPS: quantitative structure-activity relationships.

  2008cited by this paper
• Leishmaniasis: drug resistance and natural products (review).

  2008cited by this paper
• Structure-activity relationship of antibacterial chalcones.

  2008cited by this paper
• Antimicrobial and antileishmanial xanthones from the stem bark of Allanblackia gabonensis (Guttiferae)

  2008cited by this paper
• The putrescine analogue 1,4-diamino-2-butanone affects polyamine synthesis, transport, ultrastructure and intracellular survival in Leishmania amazonensis.

  2008cited by this paper
• Sodium Stibogluconate: Therapeutic use in the Management of Leishmaniasis

  2008cited by this paper
• New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate.

  2008cited by this paper
• Antiparasitic, antineuroinflammatory, and cytotoxic polyketides from the marine sponge Plakortis angulospiculatus collected in Brazil.

  2008cited by this paper
• Paromomycin in the treatment of leishmaniasis

  2008cited by this paper
• Sandfly pheromones. Their biology and potential for use in control programs.

  2008cited by this paper
• Leishmaniasis treatment—a challenge that remains: a review

  2008cited by this paper
• Novel bisbenzimidazoles with antileishmanial effectiveness.

  2008cited by this paper
• New terpenoids from Maytenus apurimacensis as MDR reversal agents in the parasite Leishmania.

  2008cited by this paper

• Review on macrophage polarization during visceral leishmaniasis and impact of glycoprotein

  2026cites this paper
• Comprehensive Insights Into Sulfanilamido‐Based Medicinal Design and Research

  2025cites this paper
• Chemometric modeling, inverse docking, and molecular simulations-driven design for multilayered prioritization of novel leishmanicidal agents based on a 2-aminobenzimidazole scaffold

  2025cites this paper
• In Vitro and In Silico Assessment of Antileishmanial Potential of Novel Tri‐ and Penta‐Valent Antimony Complexes With Phenolic Ligands

  2025cites this paper
• AntiProtoZ: An assemblage of antiprotozoal peptides

  2025cites this paper
• Computational Investigation of the Potential Antileishmanial Mechanism of the Nitroindazole Derivative VATR131

  2025cites this paper
• Hive Products: Composition, Pharmacological Properties, and Therapeutic Applications

  2024cites this paper
• Susceptibility of Leishmania to novel pentavalent organometallics: Investigating impact on DNA and membrane integrity in antimony(III)‐sensitive and ‐resistant strains

  2024cites this paper
• The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis

  2024influential citation
• Curcumin-loaded nanostructured systems for treatment of leishmaniasis: a review

  2024cites this paper
• Physalis angulata Linn. as a medicinal plant (Review)

  2024cites this paper
• Integrating traditional QSAR and read-across-based regression models for predicting potential anti-leishmanial azole compounds

  2024cites this paper
• Molecular docking, network pharmacology, and QSAR modelling studies of benzo[c]phenanthridines – novel antileishmaniasis agents

  2024cites this paper
• Development of novel dual-target drugs against visceral leishmaniasis and combinational study with miltefosine.

  2024cites this paper
• Antiparasitic activity and cytotoxic potential of the hydroethanolic extract the leaves of Tocoyena formosa

  2024cites this paper
• Exploring hydrophilic 2,2-di(indol-3-yl)ethanamine derivatives against Leishmania infantum

  2024cites this paper
• Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents

  2023cites this paper
• In vitro and in silico exploration of newly synthesized triazolyl- isonicotinohydrazides as potent antitubercular agents

  2023cites this paper
• Dual-target drugs against Leishmania donovani for potential novel therapeutics

  2023influential citation
• Novel chemical scaffold as potential drug against Leishmania donovani: Integrated computational and experimental approaches

  2023cites this paper
• Synthesis, Antileishmanial Activity and Molecular Docking Study of a Series of Dihydropyridine Derivatives

  2023cites this paper
• Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host

  2023cites this paper
• 30th Annual GP2A Medicinal Chemistry Conference

  2023cites this paper
• Journal Pre-proof and in animal infections where salvage of host sphingomyelin predominates

  2022cites this paper
• Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2H)-one Derivatives

  2022cites this paper
• A recent update on new synthetic chiral compounds with antileishmanial activity

  2022cites this paper
• Structure modifications of 2-phenylquinoline by Aspergillus genera produce novel derivatives with potent leishmanicidal and anti-inflammatory properties

  2022cites this paper
• Inositol phosphorylceramide synthase null Leishmania are viable and virulent in animal infections where salvage of host sphingomyelin predominates

  2022cites this paper
• Evaluation of the inhibitory potential of Valproic acid against histone deacetylase of Leishmania donovani and computational studies of Valproic acid derivatives

  2022cites this paper
• Photodynamic Evaluation of Triazine Appended Porphyrins as Anti-Leishmanial and Anti-tumor Agents

  2022cites this paper
• Inositol phosphorlyceramide synthase null Leishmania major are viable and virulent in animal infections where salvage of host sphingomyelin predominates

  2022cites this paper
• Krebs cycle enzymes for targeted therapeutics and immunotherapy for anti-leishmanial drug development using: Pathways, potential targets, and future perspectives.

  2022cites this paper
• Inspection of in-house designed novel thiochromone amino-acid conjugate derivatives as Lm-NMT inhibitor - An in-silico analysis.

  2022cites this paper
• N,C-Coupled naphthylisoquinoline alkaloids: a versatile new class of axially chiral natural products.

  2021cites this paper
• In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana

  2021cites this paper
• Peptides to Tackle Leishmaniasis: Current Status and Future Directions

  2021cites this paper
• Modern Drug Discovery and Development in the Area of Leishmaniasis

  2021cites this paper
• Leishmaniasis: where are we and where are we heading?

  2021cites this paper
• Molecular Informatics of Trypanothione Reductase of Leishmania major Reveals Novel Chromen-2-One Analogues as Potential Leishmanicides

  2021cites this paper
• Antileishmanial Drug Discovery and Development: Time to Reset the Model?

  2021cites this paper
• Identification of potential antileishmanial agents via structure-based molecular simulations.

  2021cites this paper
• Recent trends in the design of antimicrobial agents using Ugi-multicomponent reaction

  2021cites this paper
• Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents

  2021cites this paper
• Small Molecule–Peptide Conjugates as Dimerization Inhibitors of Leishmania infantum Trypanothione Disulfide Reductase

  2021cites this paper
• Pharmaceutical Prospects of Bee Products: Special Focus on Anticancer, Antibacterial, Antiviral, and Antiparasitic Properties

  2021cites this paper
• Topical Bambusa vulgaris Extract Enhances Wound Healing in Cutaneous Leishmaniasis

  2021cites this paper
• Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections

  2020cites this paper
• Synthesis of diverse (E)‐2‐((1 H ‐imidazol‐1‐yl)methyl)‐2‐((benzyloxy)methyl)‐2,3‐dihydro‐1 H ‐inden‐1‐one O‐benzyl oxime derivatives as potent antileishmanial agents

  2020cites this paper
• Synthesis and leishmanicidal evaluation of sulfanyl‐ and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moiety

  2020cites this paper
• Identification of Selective Inhibitors of LdDHFR Enzyme Using Pharmacoinformatic Methods

  2020influential citation
• Synthesis of N-substituted indole derivatives as potential antimicrobial and antileishmanial agents.

  2020cites this paper
• Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations

  2020cites this paper
• 1,4-Disubstituted-1,2,3-Triazole Compounds Induce Ultrastructural Alterations in Leishmania amazonensis Promastigote: An in Vitro Antileishmanial and in Silico Pharmacokinetic Study

  2020cites this paper
• Antiparasitic Behavior of Trifluoromethylated Pyrazole 2-Amino-1,3,4-thiadiazole Hybrids and Their Analogues: Synthesis and Structure-Activity Relationship

  2020cites this paper
• Antiparasitic activities of novel pyrimidine N‐acylhydrazone hybrids

  2020cites this paper
• Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds.

  2020cites this paper
• Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis.

  2020cites this paper
• Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity

  2020cites this paper
• Exploring the ability of dihydropyrimidine-5-carboxamide and 5-benzyl-2,4-diaminopyrimidine-based analogues for the selective inhibition of L. major dihydrofolate reductase.

  2020cites this paper
• Antileishmanial Chemotherapy through Clemastine Fumarate Mediated Inhibition of the Leishmania Inositol Phosphorylceramide Synthase

  2020cites this paper
• Collaborative virtual screening to elaborate an imidazo[1,2-a]pyridine hit series for visceral leishmaniasis†

  2020cites this paper
• Pyrrolopyrimidine vs imidazole-phenyl-thiazole scaffolds in non-peptidic candidates to inhibit dimerization of Leishmania infantum trypanothione reductase

  2020cites this paper
• Exploring oxidovanadium(iv) homoleptic complexes with 8-hydroxyquinoline derivatives as prospective antitrypanosomal agents

  2019cites this paper
• Synthesis and antileishmanial evaluation of thiazole orange analogs.

  2019cites this paper
• Synthesis and antileishmanial activity of fluorinated rhodacyanine analogues: The 'fluorine-walk' analysis.

  2019cites this paper
• Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5‐disubstituted isoxazole compounds based on 5‐nitrofuran scaffolds

  2019cites this paper
• Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors

  2019cites this paper
• 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action.

  2019cites this paper
• Synthesis and in vitro evaluation of substituted tetrahydroquinoline-isoxazole hybrids as anticancer agents

  2019cites this paper
• Natural and synthetic quinoline molecules against tropical parasitic pathologies: an analysis of activity and structural evolution for developing new quinoline-based antiprotozoal agents

  2019cites this paper
• Recent Advances in the Discovery of Novel Antiprotozoal Agents

  2019cites this paper
• An integrative approach using systems biology, mutational analysis with molecular dynamics simulation to challenge the functionality of a target protein

  2019cites this paper
• Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation.

  2019cites this paper
• American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short‐term possibilities for an alternative treatment

  2019cites this paper
• Need for sustainable approaches in antileishmanial drug discovery

  2019cites this paper
• Potential triazole-based molecules for the treatment of neglected diseases.

  2019cites this paper
• Design, synthesis and antitrypanosomatid activities of 3,5‐diaryl‐isoxazole analogues based on neolignans veraguensin, grandisin and machilin G

  2018cites this paper
• Substituted 1,5-naphthyridine derivatives as novel antileishmanial agents. Synthesis and biological evaluation.

  2018cites this paper
• Leishmania treatment and prevention: Natural and synthesized drugs.

  2018cites this paper
• Novel Aminoquinoline Derivatives Significantly Reduce Parasite Load in Leishmania infantum Infected Mice.

  2018cites this paper
• Discovery of benzimidazole‐based Leishmania mexicana cysteine protease CPB2.8ΔCTE inhibitors as potential therapeutics for leishmaniasis

  2018cites this paper
• Ensemble‐based ADME–Tox profiling and virtual screening for the discovery of new inhibitors of the Leishmania mexicana cysteine protease CPB2.8ΔCTE

  2018cites this paper
• Anticancer, antimicrobial and antioxidant potential of sterically tuned bis-N-heterocyclic salts

  2018cites this paper
• Systematic search for benzimidazole compounds and derivatives with antileishmanial effects

  2018cites this paper
• Preliminary investigation of novel tetra-tailed macrocycle amphiphile based nano-vesicles for amphotericin B improved oral pharmacokinetics

  2018cites this paper
• Antileishmanial Activity of Pyrazolopyridine Derivatives and Their Potential as an Adjunct Therapy with Miltefosine.

  2017cites this paper
• Synthesis, SAR and biological studies of sugar amino acid-based almiramide analogues: N-methylation leads the way.

  2017cites this paper
• Eugenol derived immunomodulatory molecules against visceral leishmaniasis.

  2017cites this paper
• Validation of Putative Apicoplast-Targeting Drugs Using a Chemical Supplementation Assay in Cultured Human Malaria Parasites

  2017cites this paper
• Effect of functionalities on the crystal structures of new zinc(II) dithiocarbamates: a combined anti-leishmanial and thermal decomposition study

  2017cites this paper
• Glycosylated metal chelators as anti-parasitic agents with tunable selectivity.

  2017cites this paper
• Antileishmanial evaluation of clubbed bis(indolyl)-pyridine derivatives: One-pot synthesis, in vitro biological evaluations and in silico ADME prediction.

  2017cites this paper
• Nanostructured delivery systems with improved leishmanicidal activity: a critical review

  2017cites this paper
• Ultrasonic treatment of CoFe2O4@B2O3-SiO2 as a new hybrid magnetic composite nanostructure and catalytic application in the synthesis of dihydroquinazolinones.

  2017cites this paper
• First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity.

  2017cites this paper
• The chemotherapeutic potential of chalcones against leishmaniases: a review.

  2017cites this paper
• Validation of putative apicoplast targeting drugs using a chemical supplementation 1 assay in cultured human malaria parasites 2 Running title : Apicoplast targeting of a panel of antimalarials

  2017cites this paper
• Individual and combined antiparasitic effect of six plant metabolites against Leishmania amazonensis and Trypanosoma cruzi.

  2016cites this paper
• Synthesis and In Vitro Anti Leishmania amazonensis Biological Screening of Morita-Baylis-Hillman Adducts Prepared from Eugenol, Thymol and Carvacrol

  2016cites this paper
• Synthesis of Novel Quaternary Ammonium Salts and Their in Vitro Antileishmanial Activity and U-937 Cell Cytotoxicity

  2016cites this paper